• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Provectus Biopharmaceuticals, Inc. (PVCT)

    -NYSE MKT
    0.52 Up 0.03(6.11%) Feb 5, 4:00PM EST
    Prev Close:0.49
    Open:0.49
    Bid:0.52 x 600
    Ask:0.65 x 7900
    1y Target Est:3.50
    Beta:1.63361
    Earnings Date:Mar 10 - Mar 14 (Est.)
    Day's Range:0.49 - 0.53
    52wk Range:0.34 - 0.99
    Volume:825,362
    Avg Vol (3m):304,524
    Market Cap:106.08M
    P/E (ttm):N/A
    EPS (ttm):-0.07
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PVCT

    Comparison

    Symbol% ChgMkt Cap
    PVCTUp 6.11%106.08M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Provectus Biopharmaceuticals, Inc., a biopharmaceutical company, engages in developing ethical pharmaceuticals for oncology and dermatology indications. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback